Navigation Links
Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
Date:12/7/2009

PARIS, December 7 /PRNewswire-FirstCall/ --

- Very Positive 3-Year Results of the Long-Term Study Provide Confirmation of the Clinical Relevance of Oralair(R)

Stallergenes S.A. today announces the 3-year results of a phase III clinical trial (VO53.06) to assess the long-term (sustained) effect and disease modifier effect after discontinuation of treatment of its sublingual grass pollen immunotherapy tablet, Oralair(R). This study is the first ever pivotal study designed to be a long-term and disease modifier trial from the outset.

The VO53.06 study is a randomized, double-blind, placebo-controlled phase III trial conducted over 5 years, 3 years as a pre- and coseasonal treatment regimen and the following 2 years without treatment. It included 633 patients, aged 18 to 50 years, with grass pollen-related allergic rhino-conjunctivitis, in 45 centers in 10 countries. The patients were divided in two treated groups and one placebo group. In the two active arms, there was no dose escalation and the daily dose was a 300 IR sublingual immunotherapy tablet. In one active arm, the treatment started 4 months before the pollen season, and in the other, 2 months before. The total treatment duration for each study-year in all groups was 5 to 6 months up until the end of the pollen season.

The sustained clinical efficacy as defined by EMEA[1] guidelines is the measurement of treatment efficacy after 3 years. The primary endpoint was the Average Adjusted Symptom Score (AASS)[2].

In the third year analysis, the two treated groups demonstrated a statistically significant reduction of AASS in comparison with placebo (p<0.0001) with a very large effect.

                 Relative differences versus placebo (season 3)


            2 months  4 months
     Mean     -36%      -34%
    Median    -50%      -48%

A reduction of 40% was achieved in the 2nd year an
'/>"/>

SOURCE Stallergenes
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
2. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
3. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amiras Lead DP2 Antagonist, AM211
4. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
5. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
6. Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
7. Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
8. Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes
9. Zydena is Efficacious in Once Daily Dosing for Erectile Dysfunction/Positive BPH Results
10. Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles.
11. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014 TWi ... Notice of Allowance for AC-201, TWi Biotechnology,s lead ... in China for patent ... its pharmaceutically acceptable salts, active metabolite for treatment ... the methods of treatment using AC-201 for type ...
(Date:12/19/2014)... HARRISBURG, Pa. , Dec. 19, 2014 ... a routine checkup and cleaning when he or she ... term you,ve probably heard before, you may have several ... You,ll be relieved to know it,s nothing to ... help answer patients, questions and alleviate any anxiety the ...
(Date:12/19/2014)... HILL, N.C. , Dec. 19, 2014 /PRNewswire/ ... to optimize a product,s web presence to reflect ... Brand websites, in particular, must meet the needs ... regulations and culture. According to ... more than half of the participating companies averaged ...
Breaking Medicine Technology:TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3Root Canals Have Become More Routine 2Building a Best-in-Class Pharma Global Brand Website 2
(Date:12/22/2014)... Harrisburg, NC (PRWEB) December 22, 2014 ... contain the current Ebola virus epidemic are ... by U.S. government agencies, nongovernmental organizations (NGOs) ... solutions remains ongoing, healthcare workers, emergency responders, ... advanced technologies such as the CmTP ...
(Date:12/22/2014)... new vaccine created to fight an illness similar to ... and even humans from similar brain infections, researchers report. ... becoming infected by the incurable brain disorder known as ... Dec. 21 online edition of the journal Vaccine ... particles known as prions that go rogue. Prion ...
(Date:12/22/2014)... December 22, 2014 The Bob ... ever, having invested more than $5 million in ... veterans and their families. , This includes $1.3 ... dozen nonprofits, helping with: veteran entrepreneurship; community impact; ... life-coaches for severely injured veterans. , “The needs ...
(Date:12/22/2014)... Explorys, the leader in big data-driven healthcare ... Greg Yarrington as Vice President of Operations, Adam Wallace ... Vice President of Solutions. These new leaders are part ... 2015 to support client demand for the company’s big ... growth of its partner network. , Since the ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Give a ... season, the gift of health and vitality. , For ... its three top-selling anti-aging formulas in special Holiday Wellness ... rush delivery. , Each bottle contains cutting-edge, proven ... that don't work as well as we age. ...
Breaking Medicine News(10 mins):Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Vaccine for Deer Against 'Mad Cow'-Like Illness Shows Promise 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2
... for bona fide media presenting official press credentials , ... facilities & IT support, English, Swedish, Spanish, German, and ... language is English] News briefings will be ... hrs CEST Monday 4 July (English), 14.00 hrs CEST ...
... more likely to suffer surgical site infections (SSIs) if the ... July issue of BJS, the British Journal of Surgery ... major abdominal surgery, exploring demographic parameters, the duration of the ... patients (17 per cent) developed SSIs and the only variable ...
... patients survive longer than Caucasians no matter how many drugs ... apparent both before and after the introduction of targeted therapies ... June issue of the Journal of Thoracic Oncology . ... of lung cancer, the non-small cell type, have a better ...
... Although gynecologic cancers account for only 10 percent of ... for 20 percent of all female cancer survivors. Because ... important to detect recurrence. The Clinical Practice Committee of ... Clinical Document outlining their expert recommendations for cancer surveillance, ...
... prior authorization for imaging services using proprietary algorithms to ... have the potential to either increase or decrease societal ... of the Journal of the American College of ... widely used by private payers to manage the utilization ...
... TUESDAY, May 31 (HealthDay News) -- Although many older diabetics ... fractures as people with osteoporosis, a new study finds. ... test to look for signs of bone loss and osteoporosis, ... with type 2 diabetes has been a question, according to ...
Cached Medicine News:Health News:European Society of Human Reproduction and Embryology Annual Meeting July 3-6, 2011, Stockholm 2Health News:European Society of Human Reproduction and Embryology Annual Meeting July 3-6, 2011, Stockholm 3Health News:Noisy operations associated with increased infections after surgery 2Health News:Asian lung cancer patient survival exceeds Caucasians' on multiple regimens 2Health News:SGO sets new standards to monitor recurrence of gynecologic cancer more effectively 2Health News:Radiology benefit managers adversely affect referring physicians, study suggests 2Health News:In Diabetics, Good Scores on Bone Tests May Not Rule Out Risk 2Health News:In Diabetics, Good Scores on Bone Tests May Not Rule Out Risk 3
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: